Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6332 | 1433 | 33.6 | 51% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1864 | 5519 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MTP PE | Author keyword | 8 | 70% | 0% | 7 |
| 2 | LIPOSOMAL MTP PE | Author keyword | 6 | 80% | 0% | 4 |
| 3 | L MTP PE | Author keyword | 4 | 67% | 0% | 4 |
| 4 | MONOCYTE CYTOTOXICITY | Author keyword | 3 | 57% | 0% | 4 |
| 5 | MURAMYL TRIPEPTIDE | Author keyword | 3 | 57% | 0% | 4 |
| 6 | TUMOR CYTOTOXICITY | Author keyword | 2 | 25% | 1% | 8 |
| 7 | FRESH TUMOR CELLS | Author keyword | 2 | 67% | 0% | 2 |
| 8 | LIVER MACROPHAGES | Author keyword | 2 | 31% | 0% | 5 |
| 9 | MIFAMURTIDE | Author keyword | 2 | 36% | 0% | 4 |
| 10 | ACTIVATED PERITONEAL MACROPHAGES | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MTP PE | 8 | 70% | 0% | 7 | Search MTP+PE | Search MTP+PE |
| 2 | LIPOSOMAL MTP PE | 6 | 80% | 0% | 4 | Search LIPOSOMAL+MTP+PE | Search LIPOSOMAL+MTP+PE |
| 3 | L MTP PE | 4 | 67% | 0% | 4 | Search L+MTP+PE | Search L+MTP+PE |
| 4 | MONOCYTE CYTOTOXICITY | 3 | 57% | 0% | 4 | Search MONOCYTE+CYTOTOXICITY | Search MONOCYTE+CYTOTOXICITY |
| 5 | MURAMYL TRIPEPTIDE | 3 | 57% | 0% | 4 | Search MURAMYL+TRIPEPTIDE | Search MURAMYL+TRIPEPTIDE |
| 6 | TUMOR CYTOTOXICITY | 2 | 25% | 1% | 8 | Search TUMOR+CYTOTOXICITY | Search TUMOR+CYTOTOXICITY |
| 7 | FRESH TUMOR CELLS | 2 | 67% | 0% | 2 | Search FRESH+TUMOR+CELLS | Search FRESH+TUMOR+CELLS |
| 8 | LIVER MACROPHAGES | 2 | 31% | 0% | 5 | Search LIVER+MACROPHAGES | Search LIVER+MACROPHAGES |
| 9 | MIFAMURTIDE | 2 | 36% | 0% | 4 | Search MIFAMURTIDE | Search MIFAMURTIDE |
| 10 | ACTIVATED PERITONEAL MACROPHAGES | 1 | 100% | 0% | 2 | Search ACTIVATED+PERITONEAL+MACROPHAGES | Search ACTIVATED+PERITONEAL+MACROPHAGES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TUMORICIDAL PROPERTIES | 33 | 52% | 3% | 45 |
| 2 | MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE | 24 | 55% | 2% | 30 |
| 3 | HUMAN BLOOD MONOCYTES | 12 | 21% | 4% | 51 |
| 4 | LIPOPHILIC MURAMYL DIPEPTIDE | 10 | 73% | 1% | 8 |
| 5 | MTP PE | 10 | 58% | 1% | 11 |
| 6 | CYTOLYTICALLY ACTIVATED MACROPHAGES | 6 | 71% | 0% | 5 |
| 7 | MURINE RENAL ADENOCARCINOMA | 4 | 67% | 0% | 4 |
| 8 | TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE | 4 | 67% | 0% | 4 |
| 9 | CGP 19835A | 4 | 75% | 0% | 3 |
| 10 | 19835A LIPID THERAPY | 3 | 100% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Mifamurtide for the treatment of nonmetastatic osteosarcoma | 2011 | 17 | 63 | 62% |
| Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma | 2006 | 43 | 74 | 76% |
| Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma | 2009 | 29 | 60 | 70% |
| MACROPHAGES AND METASTASIS - A BIOLOGICAL APPROACH TO CANCER-THERAPY - PRESIDENTIAL-ADDRESS | 1985 | 349 | 54 | 59% |
| Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases | 2008 | 9 | 66 | 65% |
| Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators | 1998 | 34 | 92 | 52% |
| RECOGNITION AND DESTRUCTION OF NEOPLASTIC-CELLS BY ACTIVATED MACROPHAGES - DISCRIMINATION OF ALTERED SELF | 1988 | 168 | 86 | 43% |
| THE CELL BIOLOGY OF MACROPHAGE ACTIVATION | 1984 | 1439 | 65 | 28% |
| THE ROLE OF NONLYMPHOID CELLS IN THE MAINTENANCE OF THE BLOOD SYSTEM ANTIGENIC HOMEOSTASIS | 2011 | 0 | 1 | 100% |
| MACROPHAGES AND CANCER | 1990 | 58 | 116 | 51% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MACROPHAGES | 1 | 100% | 0.1% | 2 |
| 2 | ANTHROPOL HUMAN BIOL | 1 | 50% | 0.1% | 1 |
| 3 | BIOL CELULAR MOLIHEM | 1 | 50% | 0.1% | 1 |
| 4 | CARDIAC SAFETY | 1 | 50% | 0.1% | 1 |
| 5 | IMMUNO DESIGNED MOL | 1 | 50% | 0.1% | 1 |
| 6 | IMMUNOL IMMUNOPHARMACOL | 1 | 50% | 0.1% | 1 |
| 7 | INSERM IFR31 | 1 | 50% | 0.1% | 1 |
| 8 | MEDLIVER GRP | 1 | 50% | 0.1% | 1 |
| 9 | MED MICROBIOLMOL VIROL SECT | 0 | 33% | 0.1% | 1 |
| 10 | PHARM NAT SYNTHET DRUGS | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000221371 | MONOCYTE MATURATION//PEPTIDE FRACTION//TUMORCYTOTOXICITY |
| 2 | 0.0000201353 | DALTONS LYMPHOMA//FK 565//POLY PLAT |
| 3 | 0.0000194972 | TOXICOL S 216 KASHIMA YODOGAWA KU//N CWS//ZAJDELA HEPATOMA |
| 4 | 0.0000154645 | WARD COLON TUMOR//MAIF//MAMMARY TUMOR BEARERS |
| 5 | 0.0000144732 | PEPTIDOGLYCAN MONOMER//ROMURTIDE//MURAMYL DIPEPTIDE |
| 6 | 0.0000130757 | MS14//CD4 MESSENGER RNA//IMMUNOL 332 N LAUDERDALE POB 318 |
| 7 | 0.0000108793 | BIOL GENET BACTERIAL CELL WALL//FC GAMMA RIII ALPHA//HUMAN INJECTIONS |
| 8 | 0.0000108295 | SALMONELLA TYPHIMURIUM VAR COPENHAGEN//FANCY PIGEON//SERV MED AVIAIRE |
| 9 | 0.0000106742 | P15E//CKS 17//ADV MED TREATMENTS |
| 10 | 0.0000093236 | ANTITUMOR IMMUN//NN BLOKCHIN CANC//HOCL SIGNALING PATHWAY |